A phase II trial of paclitaxel and epirubicin in advanced breast cancer

Initial trials of paclitaxel and doxorubicin in advanced breast cancer yielded high response rates but significant cardiac toxicity was observed. In this phase II trial we investigated the efficacy and safety of paclitaxel combined with epirubicin. Patients with advanced breast cancer, performance s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rischin, D, Smith, J, Millward, M, Lewis, C, Boyer, M, Richardson, G, Toner, G, Gurney, H, McKendrick, J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://www.ncbi.nlm.nih.gov/pubmed/10945487
http://dx.doi.org/10.1054/bjoc.2000.1306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2374646/
https://www.ncbi.nlm.nih.gov/pubmed/10945487
http://dx.doi.org/10.1054/bjoc.2000.1306

Ejemplares similares